The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro 2.5 Mg Side Effects — What UK Patients Should Know
The 2.5 mg dose of Mounjaro (tirzepatide) is the starting dose when beginning weight management treatment in the UK. Understanding the potential side effects is important before starting this prescription medication. Most side effects are mild and temporary, though some patients experience nausea or gastrointestinal changes. This guide explains what to expect, which effects are common, and when to contact your GP. Always discuss side effects with your prescriber, as individual experiences vary significantly.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Common Side Effects at 2.5 Mg Starting Dose
The 2.5 mg starting dose is designed to help your body adjust to tirzepatide gradually. At this dose, very common side effects (affecting more than 1 in 10 people in clinical trials) include nausea, diarrhoea, vomiting, constipation, and stomach pain. These gastrointestinal effects typically ease within the first few weeks as your body adapts to the medication.
- Nausea — most frequent; often improves by week 3–4
- Stomach discomfort — may feel like indigestion or cramping
- Changes in bowel habits — diarrhoea or constipation (can alternate)
- Reduced appetite — expected and part of how the medication works
Less common but reported side effects include headache, fatigue, dizziness, and injection site reactions (redness, bruising, or mild pain where you inject). The Mounjaro KwikPen delivery system minimises injection site issues compared to larger needles. Most patients find these initial effects manageable and temporary. Your prescriber may recommend eating smaller, lighter meals during the first week to reduce nausea.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS Eligibility and When to Seek Medical Attention
Mounjaro is available in the UK through NHS specialist tier 3 weight management services, though availability varies by region and waiting lists can be lengthy. You'll be assessed for eligibility based on BMI (30 or above, or 27–29.9 with weight-related conditions like type 2 diabetes or high blood pressure) before starting the 2.5 mg dose.
Seek urgent help from your GP or A&E if you experience:
- Severe, persistent stomach pain spreading to your back (possible pancreatitis)
- Serious allergic reaction (swelling of face, lips, or throat)
- Severe vomiting that prevents you keeping food or fluids down
- Signs of gallbladder problems (pain in upper stomach area)
- Chest pain or difficulty breathing
Most side effects at 2.5 mg are not serious, but your prescriber should be informed of all reactions so your dose can be managed appropriately or adjusted if needed.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is nausea at the 2.5 mg starting dose normal?
Yes, nausea is very common at the 2.5 mg starting dose — it affected over 1 in 10 people in UK clinical trials. It typically improves within the first 3–4 weeks as your body adjusts. Eating smaller, lighter meals and staying hydrated can help. If nausea persists beyond week 4, contact your prescriber.
How does Mounjaro 2.5 mg differ from Wegovy side effects?
Mounjaro is a dual GIP and GLP-1 agonist, while Wegovy (semaglutide) is a GLP-1 agonist only. Both cause similar gastrointestinal side effects, but Mounjaro's dual mechanism may produce slightly different appetite-suppressing effects. Individual responses vary significantly, and your prescriber can discuss which medication suits you.
Will side effects at 2.5 mg improve when I increase the dose?
Initially, yes — most patients experience fewer side effects as their body adapts to 2.5 mg over 4 weeks. However, when you escalate to 5 mg at week 5, some people experience mild side effects again briefly. This is expected and temporary. Gradual dose titration (increasing slowly) helps minimise this.
Can I take other medications with Mounjaro 2.5 mg?
Most medications are compatible, but Mounjaro may reduce absorption of oral contraceptives and some other oral medications. Inform your prescriber of all medications, especially birth control, diabetes drugs, and regular prescription medicines. Your prescriber will advise whether any adjustments are needed.
How do I report side effects to the NHS?
Tell your GP or the prescriber at your NHS specialist weight management service about any side effects. Serious or unexpected effects can also be reported to the MHRA (UK medicines regulator) via the Yellow Card Scheme at mhra.gov.uk — this helps monitor medication safety across the UK population.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.